فهرست مطالب

Archives of Breast Cancer - Volume:4 Issue: 2, May 2017

Archives of Breast Cancer
Volume:4 Issue: 2, May 2017

  • تاریخ انتشار: 1396/02/11
  • تعداد عناوین: 6
|
  • Luis J. Pina Pages 37-38
  • Maryam Naseri, Saeed Farzanehfar, Shaghayegh Ranjbar, Mahdieh Parvizi, Mehrshad Abbasi Pages 39-41
  • Somayyeh Borjalilu, Ahmad Kaviani, Sanaz Helmi, Mojgan Karbakhsh, Mohammad Ali Mazaheri Pages 42-57
    Background
    Self-efficacy is a psychological source for helping patients adjust with breast cancer. The aim of the present review was to synthesize the studies on self-efficacy of women with breast cancer, to determine important factors affecting the perception of self-efficacy in breast cancer as well as to describe the role of self-efficacy in the breast cancer.
    Methods
    "Self-Efficacy (SE), Cancer-Related Self-Efficacy, Symptom-Management Self-Efficacy, Women, Breast Cancer, and Breast Neoplasms" , as keywords, were searched in PubMed, CINAHL, OVID, and Web of Science from 2000 to 2016. We included only original articles published in English language, measuring self-efficacy in women with breast cancer.
    Results
    Twenty-four articles were chosen based on the inclusion criteria. The results of this review revealed that demographic variables, breast cancer diagnosis and type of treatment, bio-psycho-socio-spiritual status, and physician-patient relationship affect cancer specific SE. SE impacts on physical and mental health, pain management, quality of life, body image, clinician-patient communication, and health information seeking behavior.
    Conclusions
    This review showed that breast cancer self-efficacy is a critical component for enhancement of goal-directed behaviors in patients and it should be supported by health care providers and family members. Findings of this review has some limitations, since great amount of findings were based on cross sectional data. Further research is needed to examine the impacts of breast cancer self-efficacy on health-related variables.
    Keywords: Self-Efficacy, Symptom management, Breast cancer, Women
  • Muhammad Zubair, Iqbal Muhammad, Hassan Tariq, Rabia Ahmad, Akhter Ali, Salma Gul Pages 58-63
    Background
    B-Cell Lymphoma-2 gene is an anti-apoptotic protein associated with favorable prognosis in patients with breast cancer. The present study focused on immunohistochemical expression of the aforementioned gene with clinicopathological correlation in non-triple negative breast cancers (NTNBCs) and triple negative breast cancers (TNBCs).
    Methods
    We investigated 258 cases of primary breast cancers; they were divided into 2 groups (NTNBCs and TNBCs) based on their expression of estrogen receptor (ER), progesterone receptors (PR), and Her-2/neu receptors. BCL-2 expression was correlated with age, tumor size, tumor grade, histological subtype, lymph node status, and lymphovascular invasion (LVI).
    Results
    Among NTNBCs, 68.2% of cases expressed BCL-2 as compared to 53.3% in TNBCs (P-value = 0.035). In both groups, BCL-2 expression was significantly higher in younger patients, without lymphovascular invasion and lower grade (borderline significant in TNBCs). The variable which was associated with higher BCL-2 expression only in NTNBCs was smaller tumor size. In contrast, in TNBCs invasive ductal carcinoma was significantly associated with BCL-2 expression.
    Conclusions
    BCL-2 showed association with various clinicohistopathological characteristics in TNBC and NTNBC breast cancer patients. Yet, some of these variables were potentially related to better prognosis (the lack of LVI, smaller tumor size, and lower grade). On the other hand, younger age, which is a feature generally associated with poorer prognosis, was significantly related to BCL-2 expression.
    Keywords: B-Cell Lymphoma-2 (BCL-2), Non-Triple Negative Breast Cancers (NTNBcs), Triple Negative Breast Cancers (TNBCs), Immunohistochemistry (IHC)
  • Mehrnosh Rabbani Zadeh, Sareh Behzadi Pour Pages 64-69
    Background
    Various personality traits, like A and D, have a lot of stress, anxiety, and negative emotions that make the patients with breast cancer be susceptible to more stress and negative perception of events. Thus, the aim of the present study was to examine the association of type D personality and cognitive strategies of emotion regulation with happiness and QOL in women with breast cancer.
    Methods
    The present cross-sectional study included 100 women with breast cancer referred to Shiraz medical centers in summer 2015; the population of the study was chosen through purposive sampling method. Information was recorded through filling 4 questionnaires, including type D personality scale, cognitive emotion regulation questionnaire (CERQ), Oxford happiness inventory, and QOL questionnaire.
    Results
    A significant negative association was observed between type D personality and happiness, and there was a positive association between type D personality and QOL (P
    Conclusions
    These results elucidate the associations between personality and illness perceptions, demonstrating their close interrelatedness. Therefore, we can increase the awareness and understanding of personality traits as well as emotional regulation strategies about the disease in order to enhance happiness and quality of life in such patients.
    Keywords: Happiness_Quality of Life_Breast Cancer_Type D Personality_Cognitive Strategies of Emotion regulation
  • Massoome Najafi, Afsaneh Alikhassi, Sanaz Zand, Shahram Movafaghi, Gholamreza Toogeh Pages 75-79
    Background
    Multiple Primary Malignant Neoplasms (MPMN) is a well-known entity. Most of these tumors are metachronous. The treatment of Hodgkin lymphoma increases the risk of developing second malignancies including breast cancer. However, the synchronous occurrence of breast cancer and Hodgkin lymphoma is rare.
    Case Presentation
    We presented a case of a 31-year-old woman with simultaneous diagnosis of lobular carcinoma of the breast and Hodgkin lymphoma. The patient underwent modified radical mastectomy followed by hormone therapy as adjuvant treatment of breast cancer and simultaneous chemotherapy for Hodgkin lymphoma.
    Conclusion
    To the best of our knowledge, this is the first report of coexistence of breast cancer and Hodgkin lymphoma. Synchronous cancers present therapeutic challenges to the clinicians, and the treatment planning should be discussed in a multidisciplinary team.
    Keywords: Breast cancer, Synchronous tumor, Hodgkin lymphoma